InVision

(CDAX, Software/IT)

A n a l y s t

Fel ix El lmann

fellmann@warburg-research.com

+49 40 309537-120

CO M M E N T Published 20.10.2017 08:15 1

Buy

EUR 50.00 (EUR 60.00)

Price EUR 28.04

Upside 78.3 %

Value Indicators: EUR Share data: Description:

DCF: 49.70

Bloomberg: IVX GR

Reuters: IVXG

ISIN: DE0005859698

InVision is a leading supplier of software for WFM and for online training

Market Snapshot: EUR m Shareholders: Risk Profile (WRe): 2017e

Market cap: 62.7

No. of shares (m): 2.2

EV: 61.1

Freefloat MC: 17.9

Ø Trad. Vol. (30d): 30.60 th

Freefloat 28.5 %

InVision Holding GmbH 21.9 %

Peter Bollenbeck 17.0 %

Armand Zohari 17.0 %

Fidelity 4.3 %

Beta: 1.9

Price / Book: 5.6 x

Equity Ratio: 73 %

Hiring freeze and reorganization

Stated Figures Q3/2017: Comment on Figures: � Despite high costs, sales success in Q3 remained below expectations.

� This was already the case in Q2 (see Comment from 18.07.2017). � The company reacted with a change in management, reorganization and

a temporary hiring freeze.

In 2014, its most successful financial year to date, InVision achieved a net income of EUR 4.2m on sales of EUR 13.4m. Like today, the company

reported stable sales in the existing business and low growth in the cloud-based business areas. At that time, the company communicated margin

targets of 40% to 50% EBIT on the basis of a rather cautious (primarily profit-oriented) growth strategy. In particular, the reported figures showed the

potential earnings power Invision's business model is known to have.

Since then, the company has achieved moderate growth, although this was not visible in 2015 and 2016 due to the termination of older, non-scalable

project activities. Today, project revenues (legacy business) are just over EUR 1m p.a. (2017e, cf. 2014: EUR 3.9m). This loss was offset by significant

growth in the new business areas. In 2016, an aggressive growth strategy was implemented (+180 employees planned), supported by learned sales

processes for the new products (cloud). The main objective was to increase the number of sales staff. However, since the beginning of these efforts,

business has stagnated while costs have been rising significantly. So far, the company has not been able to convert higher selling expenses into higher

sales, which has now resulted in a hiring freeze. The resignation of board member Armand Zohari (announcement in July 2017) should also be seen in

this context. In the areas of marketing and sales, extensive restructuring measures are already underway with the aim of optimizing organizational

processes. As a result, a sales-related improvement of revenue levels is now expected to occur later than previously expected. We are confirming our

Buy recommendation with a reduced PT of EUR 50 (60).

in M io. EUR Q3/ 17 Q3/ 17e Q3/ 16 yoy 9M / 17 9M / 16 yoy

Umsatz 3 ,1 3 ,3 3,0 3,5% 9,7 9,3 4,8%

EB IT 0,2 0 ,4 0,5 -65,3% 0,9 2,6 -62,5%

M arge 6,0% 12,1% 17,9% 9,8% 27,6%

Changes in Estimates: Comment on Changes:

FY End: 31.12. in EUR m

2017e (old)

+ / - 2018e (old)

+ / - 2019e (old)

+ / -

Sales 13.8 -5.1 % 26.0 -34.6 % 32.0 -28.1 %

EBIT 1.2 -16.2 % 6.5 -71.2 % 8.0 -28.1 %

EPS 0.30 -26.7 % 2.55 -81.2 % 3.22 -31.4 %

DPS 0.00 0.0 % 0.00 0.0 % 0.00 0.0 %

� The main reason for the forecast reduction is a significant shift of the expected increase in sales revenues into the following years.

� In 2017 and the beginning of 2018, significant restructuring measures in the area of sales processes and a temporary hiring freeze will be implemented.

� An attractive earnings level is not expected until 2018 and beyond.

FY End: 31.12. in EUR m

CAGR (16-19e) 2013 2014 2015 2016 2017e 2018e 2019e

Sales 22.8 % 13.6 13.4 12.7 12.4 13.1 17.0 23.0

Change Sales yoy 2.5 % -1.1 % -5.2 % -2.2 % 5.4 % 29.8 % 35.3 %

Gross profit margin 97.6 % 98.2 % 97.1 % 97.7 % 98.0 % 98.5 % 98.5 %

EBITDA 16.3 % 2.1 4.5 3.2 4.2 1.5 2.5 6.6

Margin 15.2 % 33.6 % 25.2 % 33.6 % 11.5 % 14.5 % 28.5 %

EBIT 17.5 % 1.8 4.1 2.7 3.5 1.0 1.9 5.8

Margin 12.9 % 30.8 % 21.1 % 28.5 % 7.5 % 11.0 % 25.0 %

Net income 28.7 % 1.6 4.2 2.1 2.3 0.5 1.1 5.0

EPS 28.6 % 0.71 1.90 0.97 1.04 0.22 0.48 2.21

EPS adj. 28.2 % 0.79 1.94 0.98 1.05 0.22 0.48 2.21

DPS - 0.00 1.00 0.00 0.00 0.00 0.00 0.00

Dividend Yield n.a. 2.2 % n.a. n.a. n.a. n.a. n.a.

FCFPS 1.36 -1.48 -0.02 1.60 -0.10 -0.38 1.36

FCF / Market cap 7.4 % -3.3 % 0.0 % 3.8 % -0.4 % -1.4 % 4.8 %

EV / Sales 2.6 x 7.3 x 8.2 x 7.3 x 4.7 x 3.6 x 2.6 x

EV / EBITDA 17.3 x 21.9 x 32.6 x 21.8 x 40.6 x 25.2 x 9.0 x

EV / EBIT 20.3 x 23.9 x 39.0 x 25.7 x 62.2 x 33.2 x 10.3 x

P / E 26.1 x 23.6 x 47.9 x 40.0 x 127.4 x 58.4 x 12.7 x

P / E adj. 23.4 x 23.1 x 47.4 x 39.6 x 127.4 x 58.4 x 12.7 x

FCF Potential Yield 5.6 % -1.7 % 0.3 % 2.1 % -0.2 % -0.7 % 6.2 %

Net Debt -4.6 -0.4 1.8 -1.8 -1.5 -0.7 -3.7

ROCE (NOPAT) n.a. 97.9 % 23.4 % 24.7 % 5.2 % 10.1 % 39.8 % Guidance: 2017: Slight increase of revenues, positive earnings.

Rel. Performance vs CDAX:

1 month: -3.6 %

6 months: -8.9 %

Year to date: -35.4 %

Trailing 12 months: -49.6 %

Company events:

InVision

CO M M E N T Publ ished 20 .10 .2017 2

Sales development in EUR m

Source: Warburg Research

Cloud Computing in USD

Source: Warburg Research

EBIT development in EUR m

Source: Warburg Research

Company Background

� InVision supplies call centre employees with workforce management software and e-learning solutions

� Since 2011 InVision has been providing new cloud-based software products (software as a service, SaaS, cloud) which represent an

increasingly important source of earnings for the company

Competitive Quality

� InVision has many years of experience in the call centre and WFM field

� Cloud-based products were further developed in 2011, making InVision a first mover in the field of cloud-based WFM solutions. This

was also the case for the firm's second product range, cloud-based training

� The products in the field of SaaS possesses a very modern software architecture and structure (decentralised approach)

� Significant market entry barriers posed are development costs, acquired customer base and technological lead (first mover)

� The SaaS model is mainly of interest for the huge market of smaller users.

EBT development in EUR m

Source: Warburg Research

Sales by segments 2017e; in %

Source: Warburg Research

Net income development in EUR m

Source: Warburg Research

InVision

CO M M E N T Publ ished 20 .10 .2017 3

DCF model

Detailed forecast period Transitional period Term. Value

Figures in EUR m 2017e 2018e 2019e 2020e 2021e 2022e 2023e 2024e 2025e 2026e 2027e 2028e 2029e

Sales 13.1 17.0 23.0 30.6 39.2 48.9 59.2 68.1 75.6 83.2 91.5 94.2 97.0

Sales change 5.4 % 29.8 % 35.3 % 33.0 % 28.0 % 25.0 % 21.0 % 15.0 % 11.0 % 10.0 % 10.0 % 3.0 % 3.0 % 3.0 %

EBIT 1.0 1.9 5.8 7.6 9.8 12.2 14.8 17.0 18.9 20.8 22.9 23.6 24.3

EBIT-margin 7.5 % 11.0 % 25.0 % 25.0 % 25.0 % 25.0 % 25.0 % 25.0 % 25.0 % 25.0 % 25.0 % 25.0 % 25.0 %

Tax rate (EBT) 50.9 % 42.8 % 13.9 % 10.0 % 11.0 % 12.0 % 13.0 % 14.0 % 15.0 % 16.0 % 17.0 % 18.0 % 19.0 %

NOPAT 0.5 1.1 5.0 6.9 8.7 10.8 12.9 14.6 16.1 17.5 19.0 19.3 19.7

Depreciation 0.5 0.6 0.8 0.6 0.8 1.0 1.2 1.4 1.5 1.7 1.8 1.9 1.9

in % of Sales 4.0 % 3.5 % 3.5 % 2.0 % 2.0 % 2.0 % 2.0 % 2.0 % 2.0 % 2.0 % 2.0 % 2.0 % 2.0 %

Changes in provisions 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Change in Liquidity from

- Working Capital 0.1 0.4 1.7 1.1 1.3 1.5 1.5 1.3 1.1 1.1 1.2 -4.3 -0.7

- Capex 1.1 2.1 2.1 0.6 0.8 1.0 1.2 1.4 1.5 1.7 1.8 1.9 1.9

Capex in % of Sales 8.7 % 12.5 % 9.2 % 2.0 % 2.0 % 2.0 % 2.0 % 2.0 % 2.0 % 2.0 % 2.0 % 2.0 % 2.0 %

Other 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Free Cash Flow (WACC Model)

-0.2 -0.9 2.0 5.7 7.4 9.3 11.3 13.3 14.9 16.3 17.7 23.6 20.3 20

PV of FCF -0.2 -0.8 1.6 4.0 4.7 5.2 5.7 5.9 6.0 5.8 5.6 6.7 5.1 55 share of PVs 0.52 % 49.62 % 49.86 %

Model parameter Valuation (m)

Derivation of WACC: Derivation of Beta: Present values 2029e 55

Terminal Value 55

Debt ratio 0.00 % Financial Strength 1.80 Financial liabilities 2

Cost of debt (after tax) 4.2 % Liquidity (share) 2.00 Pension liabilities 0

Market return 7.00 % Cyclicality 1.80 Hybrid capital 0

Risk free rate 1.50 % Transparency 2.00 Minority interest 0

Others 2.00 Market val. of investments 0

Liquidity 3 No. of shares (m) 2.2

WACC 12.06 % Beta 1.92 Equity Value 111 Value per share (EUR) 49.70

Sensitivity Value per Share (EUR)

Terminal Growth Delta EBIT-margin

Beta WACC 2.25 % 2.50 % 2.75 % 3.00 % 3.25 % 3.50 % 3.75 % Beta WACC -1.5 pp -1.0 pp -0.5 pp +0.0 pp +0.5 pp +1.0 pp +1.5 pp

2.10 13.1 % 41.97 42.41 42.87 43.35 43.86 44.39 44.95 2.10 13.1 % 40.47 41.43 42.39 43.35 44.31 45.27 46.23

2.01 12.6 % 44.74 45.25 45.79 46.35 46.94 47.57 48.23 2.01 12.6 % 43.29 44.31 45.33 46.35 47.37 48.39 49.41

1.97 12.3 % 46.24 46.79 47.37 47.98 48.62 49.30 50.02 1.97 12.3 % 44.81 45.87 46.92 47.98 49.03 50.09 51.14

1.92 12.1 % 47.82 48.41 49.04 49.70 50.40 51.14 51.92 1.92 12.1 % 46.43 47.52 48.61 49.70 50.79 51.88 52.97

1.87 11.8 % 49.49 50.13 50.81 51.53 52.29 53.09 53.95 1.87 11.8 % 48.14 49.27 50.40 51.53 52.65 53.78 54.91

1.83 11.6 % 51.25 51.95 52.68 53.46 54.29 55.17 56.10 1.83 11.6 % 49.96 51.13 52.30 53.46 54.63 55.80 56.96

1.74 11.1 % 55.09 55.92 56.79 57.72 58.70 59.76 60.88 1.74 11.1 % 53.96 55.21 56.46 57.72 58.97 60.22 61.48

� High demand for cloud solutions are the basis for the revenue and earnings expectations.

� Growth stimulus is expected in the SaaS/Cloud area, which should continually increase its share of revenues.

� A tax-optimised company structure and high loss carry-forwards have an additional positive effect.

� Comment: Buying of real estate in 2014.

InVision

CO M M E N T Publ ished 20 .10 .2017 4

Valuation

2013 2014 2015 2016 2017e 2018e 2019e

Price / Book 7.7 x 11.7 x 12.3 x 8.7 x 5.6 x 5.2 x 3.7 x

Book value per share ex intangibles 1.97 3.47 3.49 4.60 4.80 5.18 7.34

EV / Sales 2.6 x 7.3 x 8.2 x 7.3 x 4.7 x 3.6 x 2.6 x

EV / EBITDA 17.3 x 21.9 x 32.6 x 21.8 x 40.6 x 25.2 x 9.0 x

EV / EBIT 20.3 x 23.9 x 39.0 x 25.7 x 62.2 x 33.2 x 10.3 x

EV / EBIT adj.* 20.3 x 23.9 x 39.0 x 25.7 x 62.2 x 33.2 x 10.3 x

P / FCF 13.6 x n.a. n.a. 26.0 x n.a. n.a. 20.7 x

P / E 26.1 x 23.6 x 47.9 x 40.0 x 127.4 x 58.4 x 12.7 x

P / E adj.* 23.4 x 23.1 x 47.4 x 39.6 x 127.4 x 58.4 x 12.7 x

Dividend Yield n.a. 2.2 % n.a. n.a. n.a. n.a. n.a.

FCF Potential Yield (on market EV) 5.6 % -1.7 % 0.3 % 2.1 % -0.2 % -0.7 % 6.2 %

*Adjustments made for: -

Company Specific Items

2013 2014 2015 2016 2017e 2018e 2019e

Market Potential Cloud Computing (Gartner) n.a. n.a. n.a. n.a. n.a. n.a. n.a. Market Potential Cloud Computing (Forrester) n.a. n.a. n.a. n.a. n.a. n.a. n.a.

InVision

CO M M E N T Publ ished 20 .10 .2017 5

Consolidated profit & loss In EUR m 2013 2014 2015 2016 2017e 2018e 2019e

Sales 13.6 13.4 12.7 12.4 13.1 17.0 23.0

Change Sales yoy 2.5 % -1.1 % -5.2 % -2.2 % 5.4 % 29.8 % 35.3 % Increase / decrease in inventory 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Own work capitalised 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Total Sales 13.6 13.4 12.7 12.4 13.1 17.0 23.0

Material expenses 0.3 0.2 0.4 0.3 0.3 0.3 0.3

Gross profit 13.2 13.2 12.3 12.1 12.8 16.7 22.7

Gross profit margin 97.6 % 98.2 % 97.1 % 97.7 % 98.0 % 98.5 % 98.5 % Personnel expenses 7.6 6.5 6.3 6.1 8.3 10.9 12.2

Other operating income 0.2 0.8 0.1 0.4 0.2 0.2 0.2

Other operating expenses 3.7 2.9 2.9 2.3 3.3 3.6 4.1

Unfrequent items 0.0 0.0 0.0 0.0 0.0 0.0 0.0

EBITDA 2.1 4.5 3.2 4.2 1.5 2.5 6.6

Margin 15.2 % 33.6 % 25.2 % 33.6 % 11.5 % 14.5 % 28.5 %

Depreciation of fixed assets 0.3 0.4 0.5 0.6 0.5 0.6 0.8

EBITA 1.8 4.1 2.7 3.5 1.0 1.9 5.8

Amortisation of intangible assets 0.0 -0.1 0.0 0.0 0.0 0.0 0.0

Goodwill amortisation 0.0 0.0 0.0 0.0 0.0 0.0 0.0

EBIT 1.8 4.1 2.7 3.5 1.0 1.9 5.8

Margin 12.9 % 30.8 % 21.1 % 28.5 % 7.5 % 11.0 % 25.0 %

EBIT adj. 1.8 4.1 2.7 3.5 1.0 1.9 5.8

Interest income 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Interest expenses 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Other financial income (loss) -0.2 0.0 0.0 0.0 0.0 0.0 0.0

EBT 1.5 4.1 2.7 3.5 1.0 1.9 5.8

Margin 11.4 % 30.2 % 21.0 % 28.0 % 7.5 % 11.0 % 25.0 % Total taxes 0.0 -0.2 0.5 1.2 0.5 0.8 0.8

Net income from continuing operations 1.6 4.2 2.1 2.3 0.5 1.1 5.0

Income from discontinued operations (net of tax) 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Net income before minorities 1.6 4.2 2.1 2.3 0.5 1.1 5.0

Minority interest 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Net income 1.6 4.2 2.1 2.3 0.5 1.1 5.0

Margin 11.4 % 31.3 % 16.8 % 18.7 % 3.7 % 6.3 % 21.5 %

Number of shares, average 2.2 2.2 2.2 2.2 2.2 2.2 2.2

EPS 0.71 1.90 0.97 1.04 0.22 0.48 2.21

EPS adj. 0.79 1.94 0.98 1.05 0.22 0.48 2.21

*Adjustments made for:

Guidance: 2017: Slight increase of revenues, positive earnings.

Financial Ratios 2013 2014 2015 2016 2017e 2018e 2019e

Total Operating Costs / Sales 84.8 % 66.4 % 74.8 % 66.4 % 88.5 % 85.5 % 71.5 %

Operating Leverage 46.2 x -124.0 x 6.7 x -14.6 x -13.3 x 3.0 x 5.9 x

EBITDA / Interest expenses n.a. n.a. n.a. 176.8 x n.a. n.a. n.a.

Tax rate (EBT) -0.6 % -3.7 % 20.1 % 33.2 % 50.9 % 42.8 % 13.9 %

Dividend Payout Ratio 0.0 % 52.5 % 0.0 % 0.0 % 0.0 % 0.0 % 0.0 %

Sales per Employee 116,867 128,931 139,644 136,538 143,956 186,813 252,747

Sales, EBITDA in EUR m

Source: Warburg Research

Operating Performance in %

Source: Warburg Research

Performance per Share

Source: Warburg Research

InVision

CO M M E N T Publ ished 20 .10 .2017 6

Consolidated balance sheet In EUR m 2013 2014 2015 2016 2017e 2018e 2019e

Assets

Goodwill and other intangible assets 0.9 0.7 0.6 0.4 0.4 0.6 0.7

thereof other intangible assets 0.9 0.7 0.6 0.4 0.4 0.6 0.7

thereof Goodwill 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Property, plant and equipment 0.7 6.8 8.8 9.5 10.1 11.5 12.7

Financial assets 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Other long-term assets 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Fixed assets 1.6 7.5 9.4 9.9 10.5 12.0 13.4

Inventories 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Accounts receivable 1.6 2.0 2.8 1.4 1.5 2.0 2.6

Liquid assets 4.6 4.4 1.4 4.0 2.8 0.9 3.7

Other short-term assets 1.1 1.3 0.7 0.5 0.5 0.5 0.5

Current assets 7.3 7.7 4.8 5.9 4.7 3.4 6.8

Total Assets 8.9 15.2 14.2 15.8 15.3 15.4 20.1

Liabilities and shareholders' equity

Subscribed capital 2.2 2.2 2.2 2.2 2.2 2.2 2.2

Capital reserve 9.2 8.0 1.2 1.2 1.2 1.2 1.2

Retained earnings 1.3 1.3 0.0 0.0 0.5 1.6 6.5

Other equity components -7.5 -3.1 4.9 7.3 7.3 7.2 7.2

Shareholders' equity 5.2 8.5 8.4 10.7 11.2 12.1 17.1

Minority interest 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Total equity 5.2 8.5 8.4 10.7 11.2 12.1 17.1

Provisions 1.6 0.9 0.6 0.2 0.2 0.2 0.2

thereof provisions for pensions and similar obligations 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Financial liabilities (total) 0.0 4.0 3.3 2.3 1.3 0.3 0.0

thereof short-term financial liabilities 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Accounts payable 0.4 0.1 0.1 0.1 0.1 0.2 0.2

Other liabilities 1.6 1.7 1.9 2.6 2.6 2.6 2.6

Liabilities 3.6 6.8 5.9 5.2 4.1 3.2 3.0

Total liabilities and shareholders' equity 8.9 15.2 14.2 15.8 15.3 15.4 20.1

Financial Ratios 2013 2014 2015 2016 2017e 2018e 2019e

Efficiency of Capital Employment

Operating Assets Turnover 7.1 x 1.5 x 1.1 x 1.2 x 1.1 x 1.3 x 1.5 x

Capital Employed Turnover 20.1 x 1.7 x 1.2 x 1.4 x 1.4 x 1.5 x 1.7 x

ROA 97.5 % 55.7 % 22.6 % 23.4 % 4.6 % 8.9 % 37.1 %

Return on Capital

ROCE (NOPAT) n.a. 97.9 % 23.4 % 24.7 % 5.2 % 10.1 % 39.8 %

ROE 32.2 % 61.3 % 25.3 % 24.3 % 4.4 % 9.2 % 33.9 %

Adj. ROE 35.8 % 62.5 % 25.6 % 24.6 % 4.4 % 9.2 % 33.9 %

Balance sheet quality

Net Debt -4.6 -0.4 1.8 -1.8 -1.5 -0.7 -3.7

Net Financial Debt -4.6 -0.4 1.8 -1.8 -1.5 -0.7 -3.7

Net Gearing -87.2 % -4.6 % 22.0 % -16.4 % -13.6 % -5.5 % -21.6 %

Net Fin. Debt / EBITDA n.a. n.a. 57.6 % n.a. n.a. n.a. n.a.

Book Value / Share 2.3 3.8 3.7 4.8 5.0 5.4 7.6

Book value per share ex intangibles 2.0 3.5 3.5 4.6 4.8 5.2 7.3

ROCE Development

Source: Warburg Research

Net debt in EUR m

Source: Warburg Research

Book Value per Share in EUR

Source: Warburg Research

InVision

CO M M E N T Publ ished 20 .10 .2017 7

Consolidated cash flow statement In EUR m 2013 2014 2015 2016 2017e 2018e 2019e

Net income 1.6 4.2 2.1 2.3 0.5 1.1 5.0

Depreciation of fixed assets 0.3 0.4 0.5 0.6 0.5 0.6 0.8

Amortisation of goodwill 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Amortisation of intangible assets 0.0 -0.1 0.0 0.0 0.0 0.0 0.0

Increase/decrease in long-term provisions 0.3 -0.5 -0.3 -0.3 0.0 0.0 0.0

Other non-cash income and expenses -0.5 -0.2 0.7 0.7 0.0 0.0 0.0

Cash Flow before NWC change 1.7 3.7 3.1 3.4 1.0 1.7 5.8

Increase / decrease in inventory 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Increase / decrease in accounts receivable 1.3 -0.5 -0.7 1.3 -0.1 -0.5 -0.6

Increase / decrease in accounts payable 0.0 -0.2 0.0 0.0 0.0 0.1 0.0

Increase / decrease in other working capital positions 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Increase / decrease in working capital (total) 1.3 -0.6 -0.7 1.3 -0.1 -0.4 -0.6

Net cash provided by operating activities [1] 3.0 3.1 2.3 4.7 0.9 1.3 5.2

Investments in intangible assets 0.0 0.0 0.0 0.0 0.0 0.1 0.1

Investments in property, plant and equipment 0.1 6.3 2.4 1.1 1.1 2.0 2.0

Payments for acquisitions 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Financial investments 0.0 -1.0 1.0 1.0 0.0 0.0 0.0

Income from asset disposals 0.0 0.2 0.0 -1.0 0.0 0.0 0.0

Net cash provided by investing activities [2] -0.1 -7.2 -1.4 -1.1 -1.1 -2.1 -2.1

Change in financial liabilities 0.0 4.0 -0.8 -1.0 -1.0 -1.0 -0.3

Dividends paid 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Purchase of own shares -0.9 -0.2 0.0 0.0 0.0 0.0 0.0

Capital measures 0.0 -0.9 -2.2 0.0 0.0 0.0 0.0

Other 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Net cash provided by financing activities [3] -0.9 2.9 -3.0 -1.0 -1.0 -1.0 -0.3

Change in liquid funds [1]+[2]+[3] 2.1 -1.2 -2.0 2.6 -1.2 -1.9 2.8

Effects of exchange-rate changes on cash 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Cash and cash equivalent at end of period 4.6 3.4 1.4 4.0 2.8 0.9 3.7

Financial Ratios 2013 2014 2015 2016 2017e 2018e 2019e

Cash Flow

FCF 3.0 -3.3 0.0 3.6 -0.2 -0.9 3.0

Free Cash Flow / Sales 21.8 % -24.3 % -0.3 % 28.7 % -1.8 % -5.0 % 13.2 %

Free Cash Flow Potential 2.0 -1.7 0.3 1.9 -0.1 -0.5 3.6

Free Cash Flow / Net Profit 190.8 % -77.6 % -1.7 % 153.7 % -48.1 % -80.0 % 61.3 %

Interest Received / Avg. Cash 0.3 % -0.7 % -1.4 % -1.5 % 0.0 % 0.0 % 0.0 %

Interest Paid / Avg. Debt n.a. 0.0 % 0.0 % 0.9 % 0.0 % 0.0 % 0.0 %

Management of Funds

Investment ratio 0.5 % 47.3 % 18.6 % 9.2 % 8.7 % 12.5 % 9.2 %

Maint. Capex / Sales 0.5 % 47.3 % 18.6 % 9.2 % 8.7 % 12.5 % 9.2 %

Capex / Dep 20.2 % 1674.5 % 450.1 % 181.9 % 217.2 % 356.5 % 263.5 %

Avg. Working Capital / Sales 14.4 % 11.6 % 17.8 % 15.9 % 10.3 % 9.4 % 9.1 %

Trade Debtors / Trade Creditors 420.1 % 1486.2 % 2370.9 % 1217.8 % 1500.0 % 1000.0 % 1300.0 %

Inventory Turnover 28.5 x 246879.0 x 373738.0 x 280700.0 x n.a. n.a. n.a.

Receivables collection period (days) 42 55 79 42 42 43 41

Payables payment period (days) 420 202 114 151 139 286 212

Cash conversion cycle (Days) -405 -202 -114 -151 n.a. n.a. n.a.

CAPEX and Cash Flow in EUR m

Source: Warburg Research

Free Cash Flow Generation

Source: Warburg Research

Working Capital

Source: Warburg Research

InVision

CO M M E N T Publ ished 20 .10 .2017 8

LEGAL DISCLAIMER

This research report (“investment recommendation” or “recommendation”) was prepared by the Warburg Research GmbH, a fully owned subsidiary of

the M.M.Warburg & CO (AG & Co.) KGaA and is passed on by the M.M.Warburg & CO (AG & Co.) KGaA. It contains selected information and does not

purport to be complete. The report is based on publicly available information and data ("the information") believed to be accurate and complete.

Warburg Research GmbH neither examines the information for accuracy and completeness, nor guarantees its accuracy and completeness. Possible

errors or incompleteness of the information do not constitute grounds for liability of M.M.Warburg & CO (AG & Co.) KGaA or Warburg Research GmbH

for damages of any kind whatsoever, and M.M.Warburg & CO (AG & Co.) KGaA and Warburg Research GmbH are not liable for indirect and/or direct

and/or consequential damages. In particular, neither M.M.Warburg & CO (AG & Co.) KGaA nor Warburg Research GmbH are liable for the statements,

plans or other details contained in these analyses concerning the examined companies, their affiliated companies, strategies, economic situations,

market and competitive situations, regulatory environment, etc. Although due care has been taken in compiling this research report, it cannot be

excluded that it is incomplete or contains errors. M.M.Warburg & CO (AG & Co.) KGaA and Warburg Research GmbH, their shareholders and

employees are not liable for the accuracy and completeness of the statements, estimations and the conclusions derived from the information contained

in this document. Provided a research report is being transmitted in connection with an existing contractual relationship, i.e. financial advisory or similar

services, the liability of M.M.Warburg & CO (AG & Co.) KGaA and Warburg Research GmbH shall be restricted to gross negligence and wilful

misconduct. In case of failure in essential tasks, M.M.Warburg & CO (AG & Co.) KGaA and Warburg Research GmbH are liable for normal negligence.

In any case, the liability of M.M.Warburg & CO (AG & Co.) KGaA and Warburg Research GmbH is limited to typical, expectable damages. This

research report does not constitute an offer or a solicitation of an offer for the purchase or sale of any security. Partners, directors or employees of

M.M.Warburg & CO (AG & Co.) KGaA, Warburg Research GmbH or affiliated companies may serve in a position of responsibility, i.e. on the board of

directors of companies mentioned in the report. Opinions expressed in this report are subject to change without notice. All rights reserved.

COPYRIGHT NOTICE

This work including all its parts is protected by copyright. Any use beyond the limits provided by copyright law without permission is prohibited and

punishable. This applies, in particular, to reproductions, translations, microfilming, and storage and processing on electronic media of the entire content

or parts thereof.

DISCLOSURE ACCORDING TO §34B OF THE GERMAN SECURITIES TRADING ACT (WHPG), THE ORDINANCE ON THE ANALYSIS OF FINANCIAL INSTRUMENTS (FINANV) AND MAR INCL. COMMISSION DELEGATED REGULATION (EU) 2016/958

The valuation underlying the investment recommendation for the company analysed here is based on generally accepted and widely used methods of

fundamental analysis, such as e.g. DCF Model, Free Cash Flow Potential, Peer Group Comparison or Sum of the Parts Model. The result of this

fundamental valuation is modified to take into consideration the analyst’s assessment as regards the expected development of investor sentiment and

its impact on the share price.

Independent of the applied valuation methods, there is the risk that the price target will not be met, for instance because of unforeseen changes in

demand for the company’s products, changes in management, technology, economic development, interest rate development, operating and/or

material costs, competitive pressure, supervisory law, exchange rate, tax rate etc. For investments in foreign markets and instruments there are further

risks, generally based on exchange rate changes or changes in political and social conditions.

This commentary reflects the opinion of the relevant author at the point in time of its compilation. A change in the fundamental factors underlying the

valuation can mean that the valuation is subsequently no longer accurate. Whether, or in what time frame, an update of this commentary follows is not

determined in advance.

Additional internal and organisational arrangements to prevent or to deal with conflicts of interest have been implemented. Among these are the spatial

separation of Warburg Research GmbH from M.M.Warburg & CO (AG & Co.) KGaA and the creation of areas of confidentiality. This prevents the

exchange of information, which could form the basis of conflicts of interest for Warburg Research in terms of the analysed issuers or their financial

instruments.

The analysts of Warburg Research GmbH do not receive a gratuity – directly or indirectly – from the investment banking activities of M.M.Warburg &

CO (AG & Co.) KGaA or of any company within the Warburg Group.

All prices of financial instruments given in this investment recommendation are the closing prices on the last stock-market trading day before the

publication date stated, unless another point in time is explicitly stated.

M.M.Warburg & CO (AG & Co.) KGaA and Warburg Research GmbH are subject to the supervision of the Federal Financial Supervisory Authority,

BaFin. M.M.Warburg & CO (AG & Co.) KGaA is additionally subject to the supervision of the European Central Bank (ECB).

SOURCES

All data and consensus estimates have been obtained from FactSet except where stated otherwise.

InVision

CO M M E N T Publ ished 20 .10 .2017 9

Additional information for clients in the United States

1. This research report (the “Report”) is a product of Warburg Research GmbH, Germany, a fully owned subsidiary of M.M.Warburg & CO (AG & Co.)

KGaA, Germany (in the following collectively “Warburg”). Warburg is the employer of the research analyst(s), who have prepared the Report. The

research analyst(s) reside outside the United States and are not associated persons of any U.S. regulated broker-dealer and therefore are not subject

to the supervision of any U.S. regulated broker-dealer.

2. The Report is provided in the United States for distribution solely to "major U.S. institutional investors" under Rule 15a-6 of the U.S. Securities

Exchange Act of 1934.

3. Any recipient of the Report should effect transactions in the securities discussed in the Report only through J.P.P. Euro-Securities, Inc., Delaware.

4. J.P.P. Euro-Securities, Inc. does not accept or receive any compensation of any kind for the dissemination of the research reports from Warburg.

Reference in accordance with section 34b of the German Securities Trading Act (WpHG), the Ordinance on the Analysis of Financial Instruments (FinAnV), MAR and Commission Delegated Regulation (EU) regarding possible conflicts of interest with companies analysed:

-1- Warburg Research, or an affiliated company, or an employee of one of these companies responsible for the compilation of the research, hold

a share of more than 5% of the equity capital of the analysed company.

-2-

Warburg Research, or an affiliated company, within the last twelve months participated in the management of a consortium for an issue in

the course of a public offering of such financial instruments, which are, or the issuer of which is, the subject of the investment

recommendation.

-3- Companies affiliated with Warburg Research manage financial instruments, which are, or the issuers of which are, subject of the

investment recommendation, in a market based on the provision of buy or sell contracts.

-4-

MMWB, Warburg Research, or an affiliated company, reached an agreement with the issuer to provide investment banking and/or

investment services and the relevant agreement was in force in the last 12 months or there arose for this period, based on the relevant

agreement, the obligation to provide or to receive a service or compensation - provided that this disclosure does not result in the disclosure of

confidential business information.

-5- The company compiling the analysis or an affiliated company had reached an agreement on the compilation of the investment

recommendation with the analysed company.

-6- Companies affiliated with Warburg Research regularly trade financial instruments of the analysed company or derivatives of these.

-6a- Warburg Research, or an affiliated company, holds a net long position of more than 0.5% of the total issued share capital of the analysed

company.

-6b- Warburg Research, or an affiliated company, holds a net short position of more than 0.5% of the total issued share capital of the analysed

company.

-6c- The issuer holds shares of more than 5% of the total issued capital of Warburg Research or an affiliated company.

-7- The company preparing the analysis as well as its affiliated companies and employees have other important interests in relation to the

analysed company, such as, for example, the exercising of mandates at analysed companies.

This report has been made accessible to the company analysed.

Company Disclosure Link to the historical price targets and rating changes (last 12 months)

InVision 3, 5 http://www.mmwarburg.com/disclaimer/disclaimer_en/DE0005859698.htm

InVision

CO M M E N T Publ ished 20 .10 .2017 10

INVESTMENT RECOMMENDATION

Investment recommendation: expected direction of the share price development of the financial instrument up to the given price target in the opinion of

the analyst who covers this financial instrument.

-B- Buy: The price of the analysed financial instrument is expected to rise over the next 12 months.

-H- Hold: The price of the analysed financial instrument is expected to remain mostly flat over the next 12

months.

-S- Sell: The price of the analysed financial instrument is expected to fall over the next 12 months.

“-“ Rating suspended: The available information currently does not permit an evaluation of the company.

WARBURG RESEARCH GMBH – ANALYSED RESEARCH UNIVERSE BY RATING

Rating Number of stocks % of Universe

Buy 106 52

Hold 88 43

Sell 9 4

Rating suspended 1 0

Total 204 100

WARBURG RESEARCH GMBH – ANALYSED RESEARCH UNIVERSE BY RATING L

L taking into account only those companies which were provided with major investment services in the last twelve months.

Rating Number of stocks % of Universe

Buy 29 73

Hold 9 23

Sell 1 3

Rating suspended 1 3

Total 40 100

PRICE AND RATING HISTORY INVISION AS OF 20.10.2017

Markings in the chart show rating changes by Warburg Research

GmbH in the last 12 months. Every marking details the date and

closing price on the day of the rating change.

InVision

CO M M E N T Publ ished 20 .10 .2017 11

EQUITIES Roland Rapelius +49 40 3282-2673 Head of Equities rrapelius@mmwarburg.com RESEARCH Michael Heider +49 40 309537-280 Jochen Reichert +49 40 309537-130 Head of Research mheider@warburg-research.com Telco, Internet, Media jreichert@warburg-research.com Henner Rüschmeier +49 40 309537-270 J. Moritz Rieser +49 40 309537-260 Head of Research hrueschmeier@warburg-research.com Real Estate mrieser@warburg-research.com Lucas Boventer +49 40 309537-290 Arash Roshan Zamir +49 40 309537-155 Renewables, Internet, Media lboventer@warburg-research.com Cap. Goods, Renewables aroshanzamir@warburg-research.com Christian Cohrs +49 40 309537-175 Malte Schaumann +49 40 309537-170 Engineering, Logistics ccohrs@warburg-research.com Technology mschaumann@warburg-research.com Felix Ellmann +49 40 309537-120 Patrick Schmidt +49 40 309537-125 Software, IT fellmann@warburg-research.com Small Cap Research pschmidt@warburg-research.com Jörg Philipp Frey +49 40 309537-258 Oliver Schwarz +49 40 309537-250 Retail, Consumer Goods jfrey@warburg-research.com Chemicals, Agriculture oschwarz@warburg-research.com Marie-Thérèse Grübner +49 40 309537-240 Marc-René Tonn +49 40 309537-259 Small Cap Research mgruebner@warburg-research.com Automobiles, Car Suppliers mtonn@warburg-research.com Ulrich Huwald +49 40 309537-255 Björn Voss +49 40 309537-254 Health Care, Pharma uhuwald@warburg-research.com Steel, Car Suppliers bvoss@warburg-research.com Thilo Kleibauer +49 40 309537-257 Alexander Wahl +49 40 309537-230 Retail, Consumer Goods tkleibauer@warburg-research.com Car Suppliers, Construction awahl@warburg-research.com Eggert Kuls +49 40 309537-256 Andreas Wolf +49 40 309537-140 Engineering ekuls@warburg-research.com Software, IT awolf@warburg-research.com Andreas Pläsier +49 40 309537-246 Banks, Financial Services aplaesier@warburg-research.com INSTITUTIONAL EQUITY SALES Holger Nass +49 40 3282-2669 Michael Kriszun +49 40 3282-2695 Head of Equity Sales, USA hnass@mmwarburg.com United Kingdom mkriszun@mmwarburg.com

Klaus Schilling +49 40 3282-2664 Marc Niemann +49 40 3282-2660 Dep. Head of Equity Sales, GER kschilling@mmwarburg.com Germany mniemann@mmwarburg.com

Tim Beckmann +49 40 3282-2665 Sanjay Oberoi +49 69 5050-7410 United Kingdom tbeckmann@mmwarburg.com United Kingdom soberoi@mmwarburg.com

Lyubka Bogdanova +49 69 5050-7411 Simon Pallhuber +49 69 5050-7414 United Kingdom, Australia lbogdanova@mmwarburg.com Switzerland, France spallhuber@mmwarburg.com

Jens Buchmüller +49 69 5050-7415 Scandinavia, Austria jbuchmueller@mmwarburg.com

Paul Dontenwill +49 40 3282-2666 Angelika Flegler +49 69 5050-7417 USA, Poland, The Netherlands pdontenwill@mmwarburg.com Roadshow/Marketing aflegler@mmwarburg.com

Matthias Fritsch +49 40 3282-2696 Juliane Willenbruch +49 40 3282-2694 United Kingdom mfritsch@mmwarburg.com Roadshow/Marketing jwillenbruch@mmwarburg.com

SALES TRADING Oliver Merckel +49 40 3282-2634 Bastian Quast +49 40 3282-2701 Head of Sales Trading omerckel@mmwarburg.com Sales Trading bquast@mmwarburg.com Elyaz Dust +49 40 3282-2702 Jörg Treptow +49 40 3282-2658 Sales Trading edust@mmwarburg.com Sales Trading jtreptow@mmwarburg.com Michael Ilgenstein +49 40 3282-2700 Jan Walter +49 40 3282-2662 Sales Trading milgenstein@mmwarburg.com Sales Trading jwalter@mmwarburg.com MACRO RESEARCH Carsten Klude +49 40 3282-2572 Dr. Christian Jasperneite +49 40 3282-2439 Macro Research cklude@mmwarburg.com Investment Strategy cjasperneite@mmwarburg.com Our research can be found under: Warburg Research http://research.mmwarburg.com/en/index.html Thomson Reuters www.thomsonreuters.com Bloomberg MMWA GO Capital IQ www.capitaliq.com FactSet www.factset.com For access please contact:

Andrea Schaper +49 40 3282-2632 Kerstin Muthig +49 40 3282-2703 Sales Assistance aschaper@mmwarburg.com Sales Assistance kmuthig@mmwarburg.com